<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="migraine/PMC6916280/results/search/drugs/results.xml">
  <result pre="demeclocycline‐HCl) 20 and 8 days before each biopsy. The use of" exact="tetracycline" post="allowed for dynamic histomorphometric analysis, in which unstained sections"/>
  <result pre="the mineralization defect was profound and therefore the uptake of" exact="tetracycline" post="label very low, mineralization lag time was calculated using"/>
  <result pre="56 instead of week 48. Another subject was treated with" exact="tetracycline" post="for sinusitis/bronchitis during the tetracycline labeling period before the"/>
  <result pre="Another subject was treated with tetracycline for sinusitis/bronchitis during the" exact="tetracycline" post="labeling period before the week 48 biopsy, requiring the"/>
  <result pre="tetracycline labeling period before the week 48 biopsy, requiring the" exact="tetracycline" post="label to be repeated and the biopsy to be"/>
  <result pre="mineralization defect was so profound at baseline and uptake of" exact="tetracycline" post="so low that imputation was needed to calculate mineralization"/>
  <result pre="amelioration in dental disease with long‐term administration of phosphorus and" exact="calcitriol" post="to adults. 25 Unlike the pivotal, double‐blind, randomized clinical"/>
  <result pre="Delvin EE . Bone response to phosphate salts, ergocalciferol, and" exact="calcitriol" post="in hypophosphatemic vitamin D‐resistant rickets . N Engl J"/>
  <result pre="in X‐linked hypophosphatemic rickets/osteomalacia. Induction and maintenance with phosphorus and" exact="calcitriol" post=". J Clin Invest. 1985; 75( 6): 1858– 68."/>
 </snippets>
</snippetsTree>
